AAMS Internal Medicine & Therapeutics · Vol. 7 · Issue 3 · 2026-03-01
Novel Oral Anticoagulants in Chronic Kidney Disease: Safety and Efficacy Meta-Analysis
Christensen H, Rashidov NK, Owusu-Mensah A
Odense University Hospital, Odense, Denmark; Republican Specialized Nephrology Center, Tashkent, Uzbekistan; Korle Bu Teaching Hospital, Accra, Ghana
Abstract
Systematic review and meta-analysis of 35 studies evaluating the safety and efficacy of NOACs compared with warfarin in 28,000 patients with CKD stages 3-5 and atrial fibrillation.
Keywords: NOAC, chronic kidney disease, anticoagulation, meta-analysis, atrial fibrillation
Full Text
Systematic review and meta-analysis of 35 studies evaluating the safety and efficacy of NOACs compared with warfarin in 28,000 patients with CKD stages 3-5 and atrial fibrillation.
This article is published open access by AAMS Internal Medicine & Therapeutics. The complete peer-reviewed text can be read on the journal page.
Author Citation Metrics
Metrics are sourced from public bibliometric records (OpenAlex) and each author's Google Scholar profile.